Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
We assessed the association between baseline vitamin D and incident TB in a prospective cohort of 6,751 HIV-negative household contacts of TB patients enrolled between September 1, 2009, and August 29, 2012, in Lima, Peru.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Systematic review.
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysis
Source: Article title.
Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysis
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysis
Systematic review · PLoS Medicine · 2019
Original publication title
Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysis
© 2019 Aibana et al
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Few studies have evaluated the association between preexisting vitamin D deficiency and incident tuberculosis (TB). We assessed the impact of baseline vitamins D levels on TB disease risk.
Source: BackgroundAbstract: Methods and findings
We assessed the association between baseline vitamin D and incident TB in a prospective cohort of 6,751 HIV-negative household contacts of TB patients enrolled between September 1, 2009, and August 29, 2012, in Lima, Peru. We screened for TB disease at 2, 6, and 12 months after enrollment. We defined cases as household contacts who developed TB disease at least 15 days after enrollment of the index patient. For each case, we randomly selected four controls from among contacts who did not develop TB disease, matching on gender and year of age.
We also conducted a one-stage individual-participant data (IPD) meta-analysis searching PubMed and Embase to identify prospective studies of vitamin D and TB disease until June 8, 2019. We included studies that assessed vitamin D before TB diagnosis. In the primary analysis, we defined vitamin D deficiency as 25: (OH)D < 50 nmol/L, insufficiency as 50 to 75 nmol/L, and sufficiency as >75nmol/L. We estimated the association between baseline vitamin D status and incident TB using conditional logistic regression in the Lima cohort and generalized linear mixed models in the meta-analysis.
We further defined severe vitamin D deficiency as 25: (OH)D < 25 nmol/L and performed stratified analyses by HIV status in the IPD meta-analysis. In the Lima cohort, we analyzed 180 cases and 709 matched controls. The adjusted odds ratio (aOR) for TB risk among participants with baseline vitamin D deficiency compared to sufficient vitamin D was 1.63 (95% CI 0.75 to 3.52; p = 0.22). We included seven published studies in the meta-analysis and analyzed 3,544 participants. In the pooled analysis, the aOR was 1.48 (95% CI 1.04 to 2.10; p = 0.03).
The aOR for severe vitamin D deficiency was 2.05 (95% CI 0.87 to 4.87; p trend for decreasing 25: (OH)D levels from sufficient vitamin D to severe deficiency = 0.02). Among 1,576 HIV-positive patients, vitamin D deficiency conferred a 2-fold (aOR 2.18, 95% CI 1.22 to 3.90; p = 0.01) increased risk of TB, and the aOR for severe vitamin D deficiency compared to sufficient vitamin D was 4.28 (95% CI 0.85 to 21.45; p = 0.08). Our Lima cohort study is limited by the short duration of follow-up, and the IPD meta-analysis is limited by the number of possible confounding covariates available across all studies.
Source: Methods and findingsAbstract: Why was this study done?
Although multiple lines of evidence suggest that vitamin D may play a role in host susceptibility to tuberculosis (TB) disease, the impact of low vitamin D on the risk of developing TB disease has not yet been firmly established.
Abstract: What did the researchers do and find?
We conducted a study in Lima, Peru, in which we measured serum 25: (OH)D levels in individuals at high risk for TB disease and followed them for development of TB over 1 year.
We pooled individual-level data from seven previously published prospective studies conducted worldwide and from our Lima cohort.
We found that individuals with low levels of vitamin D were at higher risk of future progression to TB disease.
Abstract: What do these findings mean?
These findings suggest that vitamin D deficiency is a risk factor for developing TB disease.
Randomized control trials are needed to determine whether vitamin D supplementation reduces risk of TB disease.
Abstract: Conclusion
Our findings suggest vitamin D predicts TB disease risk in a dose-dependent manner and that the risk of TB disease is highest among HIV-positive individuals with severe vitamin D deficiency. Randomized control trials are needed to evaluate the possible role of vitamin D supplementation on reducing TB disease risk.
Source: ConclusionAuthors’ abstract
Background
Few studies have evaluated the association between preexisting vitamin D deficiency and incident tuberculosis (TB). We assessed the impact of baseline vitamins D levels on TB disease risk.
Methods and findings
We assessed the association between baseline vitamin D and incident TB in a prospective cohort of 6,751 HIV-negative household contacts of TB patients enrolled between September 1, 2009, and August 29, 2012, in Lima, Peru. We screened for TB disease at 2, 6, and 12 months after enrollment. We defined cases as household contacts who developed TB disease at least 15 days after enrollment of the index patient. For each case, we randomly selected four controls from among contacts who did not develop TB disease, matching on gender and year of age.
We also conducted a one-stage individual-participant data (IPD) meta-analysis searching PubMed and Embase to identify prospective studies of vitamin D and TB disease until June 8, 2019. We included studies that assessed vitamin D before TB diagnosis. In the primary analysis, we defined vitamin D deficiency as 25: (OH)D < 50 nmol/L, insufficiency as 50 to 75 nmol/L, and sufficiency as >75nmol/L. We estimated the association between baseline vitamin D status and incident TB using conditional logistic regression in the Lima cohort and generalized linear mixed models in the meta-analysis.
We further defined severe vitamin D deficiency as 25: (OH)D < 25 nmol/L and performed stratified analyses by HIV status in the IPD meta-analysis. In the Lima cohort, we analyzed 180 cases and 709 matched controls. The adjusted odds ratio (aOR) for TB risk among participants with baseline vitamin D deficiency compared to sufficient vitamin D was 1.63 (95% CI 0.75 to 3.52; p = 0.22). We included seven published studies in the meta-analysis and analyzed 3,544 participants. In the pooled analysis, the aOR was 1.48 (95% CI 1.04 to 2.10; p = 0.03).
The aOR for severe vitamin D deficiency was 2.05 (95% CI 0.87 to 4.87; p trend for decreasing 25: (OH)D levels from sufficient vitamin D to severe deficiency = 0.02). Among 1,576 HIV-positive patients, vitamin D deficiency conferred a 2-fold (aOR 2.18, 95% CI 1.22 to 3.90; p = 0.01) increased risk of TB, and the aOR for severe vitamin D deficiency compared to sufficient vitamin D was 4.28 (95% CI 0.85 to 21.45; p = 0.08). Our Lima cohort study is limited by the short duration of follow-up, and the IPD meta-analysis is limited by the number of possible confounding covariates available across all studies.
Conclusion
Our findings suggest vitamin D predicts TB disease risk in a dose-dependent manner and that the risk of TB disease is highest among HIV-positive individuals with severe vitamin D deficiency. Randomized control trials are needed to evaluate the possible role of vitamin D supplementation on reducing TB disease risk.
Author summary
Why was this study done?
Although multiple lines of evidence suggest that vitamin D may play a role in host susceptibility to tuberculosis (TB) disease, the impact of low vitamin D on the risk of developing TB disease has not yet been firmly established.
What did the researchers do and find?
We conducted a study in Lima, Peru, in which we measured serum 25: (OH)D levels in individuals at high risk for TB disease and followed them for development of TB over 1 year.
We pooled individual-level data from seven previously published prospective studies conducted worldwide and from our Lima cohort.
We found that individuals with low levels of vitamin D were at higher risk of future progression to TB disease.
What do these findings mean?
These findings suggest that vitamin D deficiency is a risk factor for developing TB disease.
Randomized control trials are needed to determine whether vitamin D supplementation reduces risk of TB disease.
Publication and source details
Original title: Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysis
Omowunmi Aibana; Chuan-Chin Huang; Said Aboud; Alberto Arnedo-Pena; Mercedes C. Becerra; Juan Bautista Bellido-Blasco; Ramesh Bhosale; Roger Calderon; Silvia Chiang; Carmen Contreras; Ganmaa Davaasambuu; Wafaie W. Fawzi; Molly F. Franke; Jerome T. Galea; Daniel Garcia-Ferrer; Maria Gil-Fortuño; Barbará Gomila-Sard; Amita Gupta; Nikhil Gupte; Rabia Hussain; Jesus Iborra-Millet; Najeeha T. Iqbal; Jose Vicente Juan-Cerdán; Aarti Kinikar; Leonid Lecca; Vidya Mave; Noemi Meseguer-Ferrer; Grace Montepiedra; Ferdinand M. Mugusi; Olumuyiwa A. Owolabi; Julie Parsonnet; Freddy Roach-Poblete; Maria Angeles Romeu-García; Stephen A. Spector; Christopher R. Sudfeld; Mark W. Tenforde; Toyin O. Togun; Rosa Yataco; Zibiao Zhang; Megan B. Murray
PLoS Medicine · 2019
The authors of this manuscript have the following competing interests: MBM is a member of the Editorial Board of PLOS Medicine. All other authors have declared no competing interests.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T03:30:20.275352+00:00
DOI: 10.1371/journal.pmed.1002907 · PMC6738590